Hansoh Pharmaceutical Group Co Ltd 03692
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- HK$21.85
- Day Range
- HK$20.60–22.00
- 52-Week Range
- HK$9.73–22.10
- Bid/Ask
- HK$20.95 / HK$21.00
- Market Cap
- HK$124.62 Bil
- Volume/Avg
- 6.2 Mil / 5.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 25.94
- Price/Sales
- 10.01
- Dividend Yield (Trailing)
- 1.57%
- Dividend Yield (Forward)
- 1.57%
- Total Yield
- 1.57%
Company Profile
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 9,099
- Website
- https://www.hspharm.com
Comparables
Valuation
|
Metric
|
03692
|
002038
|
600812
|
|---|---|---|---|
Price/Earnings (Normalized) | 25.94 | 48.20 | 6,710.21 |
Price/Book Value | 4.39 | 1.40 | 1.82 |
Price/Sales | 10.01 | 9.56 | 0.89 |
Price/Cash Flow | 27.89 | 26.14 | 6.24 |
Price/Earnings
03692
002038
600812
Financial Strength
|
Metric
|
03692
|
002038
|
600812
|
|---|---|---|---|
Quick Ratio | 7.81 | 7.46 | 0.50 |
Current Ratio | 7.98 | 13.53 | 0.77 |
Interest Coverage | 68.15 | — | 1.41 |
Quick Ratio
03692
002038
600812
Profitability
|
Metric
|
03692
|
002038
|
600812
|
|---|---|---|---|
Return on Assets (Normalized) | 14.94% | 2.60% | 0.04% |
Return on Equity (Normalized) | 18.77% | 2.77% | 0.15% |
Return on Invested Capital (Normalized) | 14.08% | 2.57% | 1.97% |
Return on Assets
03692
002038
600812
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Gctjtwgvz | Pzghg | $87.2 Bil | |||
| Merck KGaA ADR
MKKGY
| Rvtkbzdkd | Xnxxh | $75.7 Bil | |||
| Haleon PLC ADR
HLN
| Wbgttwvc | Pgkjq | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Prxdgzxf | Npgh | $20.0 Bil | |||
| Viatris Inc
VTRS
| Pyqkmlyrz | Fcs | $13.7 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Rzjdrfxh | Wnwj | $13.4 Bil | |||
| Catalent Inc
CTLT
| Nclyvzh | Qkhwjx | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Pvdqgkhtj | Spsxp | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Htsjggs | Wrsh | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Gmhxvzbj | Hvkd | $2.4 Bil |
United States